268 related articles for article (PubMed ID: 27434442)
21. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
[TBL] [Abstract][Full Text] [Related]
22. Fertility treatments and the risk for ophthalmic complications: a cohort study with 25-year follow-up.
Ratson R; Sheiner E; Davidson E; Sergienko R; Beharier O; Kessous R
J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3094-7. PubMed ID: 26697760
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes.
Sunkara SK; La Marca A; Seed PT; Khalaf Y
Hum Reprod; 2015 Jun; 30(6):1473-80. PubMed ID: 25883033
[TBL] [Abstract][Full Text] [Related]
24. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.
Lerner-Geva L; Rabinovici J; Olmer L; Blumstein T; Mashiach S; Lunenfeld B
Gynecol Endocrinol; 2012 Oct; 28(10):809-14. PubMed ID: 22475084
[TBL] [Abstract][Full Text] [Related]
25. IVF and breast cancer: a systematic review and meta-analysis.
Sergentanis TN; Diamantaras AA; Perlepe C; Kanavidis P; Skalkidou A; Petridou ET
Hum Reprod Update; 2014; 20(1):106-23. PubMed ID: 23884897
[TBL] [Abstract][Full Text] [Related]
26. Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case-control study.
Katz D; Paltiel O; Peretz T; Revel A; Sharon N; Maly B; Michan N; Sklair-Levy M; Allweis T
Breast J; 2008; 14(6):517-22. PubMed ID: 19000041
[TBL] [Abstract][Full Text] [Related]
27. Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women.
Klip H; van Leeuwen FE; Schats R; Burger CW;
Hum Reprod; 2003 Sep; 18(9):1951-8. PubMed ID: 12923156
[TBL] [Abstract][Full Text] [Related]
28. The effect of endometrial injury on ongoing pregnancy rate in unselected subfertile women undergoing in vitro fertilization: a randomized controlled trial.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Hum Reprod; 2014 Nov; 29(11):2474-81. PubMed ID: 25205759
[TBL] [Abstract][Full Text] [Related]
29. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
Das M; Shehata F; Son WY; Tulandi T; Holzer H
Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
[TBL] [Abstract][Full Text] [Related]
30. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
[TBL] [Abstract][Full Text] [Related]
31. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF.
Klip H; Burger CW; de Kraker J; van Leeuwen FE;
Hum Reprod; 2001 Nov; 16(11):2451-8. PubMed ID: 11679537
[TBL] [Abstract][Full Text] [Related]
32. Cancer risk among Danish women with cosmetic breast implants.
Friis S; Hölmich LR; McLaughlin JK; Kjøller K; Fryzek JP; Henriksen TF; Olsen JH
Int J Cancer; 2006 Feb; 118(4):998-1003. PubMed ID: 16152592
[TBL] [Abstract][Full Text] [Related]
33. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis.
Siristatidis C; Sergentanis TN; Kanavidis P; Trivella M; Sotiraki M; Mavromatis I; Psaltopoulou T; Skalkidou A; Petridou ET
Hum Reprod Update; 2013; 19(2):105-23. PubMed ID: 23255514
[TBL] [Abstract][Full Text] [Related]
34. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
35. Increased time to pregnancy is associated with less optimal neurological condition in 4-year-old singletons, in vitro fertilization itself is not.
Schendelaar P; Van den Heuvel ER; Heineman MJ; La Bastide-Van Gemert S; Middelburg KJ; Seggers J; Hadders-Algra M
Hum Reprod; 2014 Dec; 29(12):2773-86. PubMed ID: 25316454
[TBL] [Abstract][Full Text] [Related]
36. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.
Venn A; Jones P; Quinn M; Healy D
Gynecol Oncol; 2001 Jul; 82(1):64-8. PubMed ID: 11426963
[TBL] [Abstract][Full Text] [Related]
38. Fertility treatments and pediatric neoplasms of the offspring: results of a population-based cohort with a median follow-up of 10 years.
Wainstock T; Walfisch A; Shoham-Vardi I; Segal I; Harlev A; Sergienko R; Landau D; Sheiner E
Am J Obstet Gynecol; 2017 Mar; 216(3):314.e1-314.e14. PubMed ID: 28153657
[TBL] [Abstract][Full Text] [Related]
39. Does ovarian stimulation for IVF increase gynaecological cancer risk? A systematic review and meta-analysis.
Zhao J; Li Y; Zhang Q; Wang Y
Reprod Biomed Online; 2015 Jul; 31(1):20-9. PubMed ID: 26003452
[TBL] [Abstract][Full Text] [Related]
40. Tumour incidence in Swedish women who gave birth following IVF treatment.
Kristiansson P; Björ O; Wramsby H
Hum Reprod; 2007 Feb; 22(2):421-6. PubMed ID: 17071821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
